Bogle Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-30,550
| Closed | -$2.61M | – | 349 |
|
|
2018
Q3 | $2.61M | Sell |
30,550
-68,081
| -69% | -$5.82M | 0.19% | 133 |
|
|
2018
Q2 | $11.4M | Buy |
98,631
+36,730
| +59% | +$4.26M | 0.83% | 58 |
|
|
2018
Q1 | $5.01M | Buy |
+61,901
| New | +$5.01M | 0.38% | 95 |
|
|
2017
Q4 | – | Sell |
-37,967
| Closed | -$1.78M | – | 304 |
|
|
2017
Q3 | $1.78M | Buy |
+37,967
| New | +$1.78M | 0.12% | 169 |
|
|
2017
Q2 | – | Sell |
-12,510
| Closed | -$385K | – | 321 |
|
|
2017
Q1 | $385K | Buy |
+12,510
| New | +$385K | 0.03% | 272 |
|
|
2016
Q4 | – | Sell |
-13,832
| Closed | -$368K | – | 350 |
|
|
2016
Q3 | $368K | Buy |
+13,832
| New | +$368K | 0.03% | 318 |
|
|
2013
Q4 | – | Sell |
-53,863
| Closed | -$1.23M | – | 315 |
|
|
2013
Q3 | $1.23M | Buy |
+53,863
| New | +$1.23M | 0.13% | 205 |
|